Compounds > cystine

cystine and von Willebrand Diseases

cystine has been researched along with von Willebrand Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brassard, J; Budde, U; Mainusch, K; Obser, T; Oldenburg, J; Ruggeri, ZM; Schneppenheim, R; Schneppenheim, S; Schwaab, R1
Bodó, I; Dong, Z; Eikenboom, JC; Katsumi, A; Sadler, JE; Tuley, EA1
Ajzenberg, N; Baruch, D; Legendre, P; Meyer, D; Rastegar-Lari, G; Ribba, AS; Vereycken-Holler, V; Villoutreix, B1

Other Studies

3 other study(ies) available for cystine and von Willebrand Diseases

ArticleYear
Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.
    Blood, 2001, Apr-01, Volume: 97, Issue:7

    Topics: Adult; Amino Acid Substitution; Animals; Chlorocebus aethiops; COS Cells; Cystine; Dimerization; DNA Mutational Analysis; Female; Frameshift Mutation; Gene Expression; Heterozygote; Humans; Male; Mutation, Missense; Pedigree; Phenotype; Protein Conformation; Recombinant Fusion Proteins; Sequence Deletion; Structure-Activity Relationship; Transfection; von Willebrand Diseases; von Willebrand Factor

2001
Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins.
    Blood, 2001, Nov-15, Volume: 98, Issue:10

    Topics: Amino Acid Substitution; Animals; Cell Line; Chlorocebus aethiops; COS Cells; Cricetinae; Cysteine; Cysteine Endopeptidases; Cystine; Dimerization; Endoplasmic Reticulum; Genes, Dominant; Humans; Intracellular Fluid; Mesocricetus; Models, Genetic; Multienzyme Complexes; Mutation, Missense; Point Mutation; Proteasome Endopeptidase Complex; Protein Structure, Tertiary; Sequence Deletion; Transfection; von Willebrand Diseases; von Willebrand Factor

2001
Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:6

    Topics: Amino Acid Substitution; Animals; Antibodies, Monoclonal; Binding Sites; Chlorocebus aethiops; Codon; COS Cells; Cystine; Heparin; Humans; Hydrogen Bonding; Models, Molecular; Mutation, Missense; Platelet Glycoprotein GPIb-IX Complex; Point Mutation; Protein Binding; Protein Conformation; Protein Denaturation; Protein Folding; Protein Interaction Mapping; Recombinant Fusion Proteins; Ristocetin; Structure-Activity Relationship; Surface Properties; Transfection; von Willebrand Diseases; von Willebrand Factor

2001